RISK FACTORS FOR DIABETIC NEPHROPATHY AMONG NON INSULIN DEPENDENT PATIENTS WHO ATTENDED CITY HALL'S STAFF CLINIC IN KUALA LUMPUR
DOI:
https://doi.org/10.37268/mjphm/vol.1/no.1/art.1216Keywords:
Diabetes mellitus (NIDDM), nephropathy, risk factorsAbstract
Diabetes mellitus and its main complication, nephropathy, affects the economic wellbeing and quality of life of the sufferers and the population. A matched case control study was conducted in September 1998 to investigate the factors involved with nephropathy such as diabetic control, smoking, hypertension, family history of diabetes and diabetic duration. Respondents were classified based on the presence of microalbuminuria or macroalbuminuria. Seventy-two pairs of case and control were studied. Duration of diabetes (p = 0.005), presence of lethargy and weakness prior to diabetes diagnosis (p = 0.019), duration of smoking (p = 0.014), duration of hypertension (p= 0.000), systolic hypertension (p= 0.025), uncontrolled diabetes with poor HbAlc level (p= 0.026) and lack of diabetes knowledge (p = 0.037) were factors which related significantly to nephropathy by univariate analysis. In multivariate analysis, systolic hypertension (p = 0.0015), lack of diabetes knowledge (p = 0.0197), presence of lethargy symptom (p = 0.0027), prolonged diabetic duration (p = 0.0301) and higher body mass indices ( p = 0.0213) were predictors to diabetic nephropathy.
References
2. Mattock MB, Morrish N, Viberti G, Keen H, Fitzgerald AP, Jackson G. Prospective study of rnicroalburninuria as predictor of mortality in NIDDM. Diabetes 1992; 41: 736-741
3. Damsgaard EM, Froland A., Jorgensen OD, Mogensen CE. Eight to nine year mortality in known NIDDM and controls. Kidney
International 1992; 41: 731-735
4. DeFronzo RA. Diabetic Nephropathy. In Junior DP &·Sherwin RS. (eds). Diabetes Mellitus 1997. Connecticut: Appleton & Lange.
5. Klein R, Elein BEK, Moss S'.J, Cruickshanks KJ. Ten year incidence of gross proteinuria in people with diabetes. Diabetes 1995; (44): 916- 923
6. Sawicki PT, Didjurgeit U, Mulhauser I, Bender R, Heinemann L & Berger M. Smoking is associated with progression of diabetic nephropathy. Diabetes Care 1994; 2 (17) : 126- 131
7. DCCT Research Group. The Effect of-intensive treatment of diabetes on the development and progression of long term complications in IDDM. The New England Journal of Medicine 1993; 329: 977-986
8. Gall MA, Haugaard P, Jojnsen KB, Parving HH. Risk factors for development of incipient and overt diabetic nephropathy in patients with NIDDM prospective, observational study. British Medical J; 1997; 314: 783-788.
9. Schmitz A, Vaeth M, Mogensen CE. Systolic blood pressure relates to the rate of progression of alburninuria in NIDDM. Diabetologia 1994; 37: 1251-1258.
10. Neil A, Hawkins M, Polak M, Thorogard M, Cohen D, Mann J. A prospective population based study of rnicroalburninuria as a predictive of mortality in NIDDM. Diabetes care 1993; (16) 7: 996-1003.
11. Microalburninuria Collaborative Study Group, U.K. Risk factor for development of rnicroalburninuria in IDDM patients : A cohort study. British Medical J. 1993; 306 :1235-1240.
12. Powrie JK, Watts GF, Ingham JN, Taub NA, Talmud PJ, Shaw KM. Role of glycernic control in development of microalbuminuria in patients with insulin dependent diabetes. British Medical J 1994; 309: 1608-1612.
